Zhongzhu Medical Holdings Co Ltd Cash Flow Conversion Efficiency

Latest as of September 2025: 0.016x

Zhongzhu Medical Holdings Co Ltd cash flow conversion efficiency. Based on the latest financial reports, Zhongzhu Medical Holdings Co Ltd (600568) has a cash flow conversion efficiency ratio of 0.016x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥26.78 Million ≈ $3.92 Million USD) by net assets (CN¥1.71 Billion ≈ $250.64 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Zhongzhu Medical Holdings Co Ltd (1999–2025)

Cash flow conversion efficiency of Zhongzhu Medical Holdings Co Ltd from 1999 to 2025. This chart illustrates how Zhongzhu Medical Holdings Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. View Zhongzhu Medical Holdings Co Ltd (600568) stock price for real-time trading data and today's change.

Zhongzhu Medical Holdings Co Ltd Cash Flow Conversion Ratio Explained

Zhongzhu Medical Holdings Co Ltd cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Zhongzhu Medical Holdings Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Zhongzhu Medical Holdings Co Ltd ranked by their cash flow conversion efficiency. Also see Zhongzhu Medical Holdings Co Ltd stock valuation for the company's overall valuation and market capitalisation.

Company Cash Flow Conversion Efficiency
Song Da Urban & Industrial Zone Investment and Development JSC
VN:SJS
-0.118x
GeoPark Ltd
NYSE:GPRK
0.293x
Zhejiang Shengyang Science
SHG:603703
0.010x
Shanghai Join Buy Co Ltd
SHG:600838
0.003x
RVRC Holding AB
ST:RVRC
0.014x
JinkoSolar Holding Co. Ltd
F:ZJS1
0.075x
Qian Jiang Water Resources Development Co Ltd
SHG:600283
0.031x
Chimera Investment Corporation
NYSE:CIM
-0.040x

Annual Cash Flow Conversion Efficiency for Zhongzhu Medical Holdings Co Ltd (1999–2025)

The table below shows the annual cash flow conversion efficiency of Zhongzhu Medical Holdings Co Ltd from 1999 to 2025. Review Zhongzhu Medical Holdings Co Ltd free cash flow efficiency to assess how much free cash flow the company generates relative to operating cash flow.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 CN¥1.63 Billion
≈ $238.63 Million
CN¥56.08 Million
≈ $8.21 Million
0.034x +83.70%
2024-12-31 CN¥1.74 Billion
≈ $255.02 Million
CN¥32.63 Million
≈ $4.77 Million
0.019x +1649.82%
2023-12-31 CN¥2.59 Billion
≈ $379.07 Million
CN¥2.77 Million
≈ $405.57K
0.001x -87.69%
2022-12-31 CN¥2.94 Billion
≈ $429.73 Million
CN¥25.52 Million
≈ $3.74 Million
0.009x -65.54%
2021-12-31 CN¥3.73 Billion
≈ $545.62 Million
CN¥94.04 Million
≈ $13.76 Million
0.025x -59.55%
2020-12-31 CN¥3.98 Billion
≈ $582.38 Million
CN¥248.15 Million
≈ $36.31 Million
0.062x -60.51%
2019-12-31 CN¥3.89 Billion
≈ $569.54 Million
CN¥614.57 Million
≈ $89.93 Million
0.158x +351.03%
2018-12-31 CN¥4.26 Billion
≈ $622.92 Million
CN¥-267.76 Million
≈ $-39.18 Million
-0.063x -7.91%
2017-12-31 CN¥6.15 Billion
≈ $899.41 Million
CN¥-358.29 Million
≈ $-52.43 Million
-0.058x -218.18%
2016-12-31 CN¥6.01 Billion
≈ $879.82 Million
CN¥296.58 Million
≈ $43.40 Million
0.049x -30.98%
2015-12-31 CN¥2.65 Billion
≈ $387.06 Million
CN¥189.05 Million
≈ $27.66 Million
0.071x +1185.81%
2014-12-31 CN¥2.58 Billion
≈ $377.47 Million
CN¥14.34 Million
≈ $2.10 Million
0.006x +84.24%
2013-12-31 CN¥1.18 Billion
≈ $172.51 Million
CN¥3.56 Million
≈ $520.44K
0.003x +106.40%
2012-12-31 CN¥1.03 Billion
≈ $150.39 Million
CN¥-48.43 Million
≈ $-7.09 Million
-0.047x +42.30%
2011-12-31 CN¥915.88 Million
≈ $134.02 Million
CN¥-74.80 Million
≈ $-10.94 Million
-0.082x +88.58%
2010-12-31 CN¥742.77 Million
≈ $108.69 Million
CN¥-531.24 Million
≈ $-77.74 Million
-0.715x -91.30%
2009-12-31 CN¥677.27 Million
≈ $99.11 Million
CN¥-253.20 Million
≈ $-37.05 Million
-0.374x -353.89%
2008-12-31 CN¥616.24 Million
≈ $90.17 Million
CN¥90.74 Million
≈ $13.28 Million
0.147x +2020.96%
2007-12-31 CN¥514.98 Million
≈ $75.36 Million
CN¥3.58 Million
≈ $523.18K
0.007x -93.14%
2006-12-31 CN¥479.24 Million
≈ $70.13 Million
CN¥48.49 Million
≈ $7.10 Million
0.101x -1.27%
2005-12-31 CN¥558.76 Million
≈ $81.76 Million
CN¥57.27 Million
≈ $8.38 Million
0.102x +1726.33%
2004-12-31 CN¥489.48 Million
≈ $71.63 Million
CN¥2.75 Million
≈ $401.95K
0.006x +380.94%
2003-12-31 CN¥472.91 Million
≈ $69.20 Million
CN¥551.80K
≈ $80.75K
0.001x -8.44%
2002-12-31 CN¥444.66 Million
≈ $65.07 Million
CN¥566.66K
≈ $82.92K
0.001x -87.95%
2001-12-31 CN¥433.47 Million
≈ $63.43 Million
CN¥4.59 Million
≈ $671.09K
0.011x -69.40%
2000-12-31 CN¥82.36 Million
≈ $12.05 Million
CN¥2.85 Million
≈ $416.77K
0.035x -64.08%
1999-12-31 CN¥69.76 Million
≈ $10.21 Million
CN¥6.72 Million
≈ $982.65K
0.096x --

About Zhongzhu Medical Holdings Co Ltd

SHG:600568 China Drug Manufacturers - Specialty & Generic
Market Cap
$612.40 Million
CN¥4.19 Billion CNY
Market Cap Rank
#10886 Global
#2962 in China
Share Price
CN¥2.10
Change (1 day)
+0.96%
52-Week Range
CN¥1.94 - CN¥3.21
All Time High
CN¥9.91
About

Zhongzhu Healthcare Holding Co.,Ltd engages in the research and development, production, and sale of drugs in China. The company offers Ophthalmic drugs, including pearl brightening eye drops, clindamycin phosphate for injection, acyclovir dispersible tablets, sodium cromoglycate eye drops, acyclovir for injection, diclofenac sodium suppositories, diclofenac sodium liniment, azithromycin granules… Read more